Teddy Lonczak

For twenty years Topical BioMedics, Inc., a Certified B Corporation, has established itself as the R&D leader of topical natural cellular biomedicines for relieving pain by providing Topricin topical healing technology to enhance and support the body’s ability to heal the damage that is causing the pain. The company’s primary work and mission is to drive an integrated evolving model for medicine--one where safe and effective treatments are widely available, and where no one has to live in pain. Cornerstones of a robust, sustainable health care model. Topical BioMedics'​ research-based biopharmaceutical solutions developed by Lou Paradise, President and Chief of Research, are at the core of Topical BioMedics, Inc. work. The company believes there is a much deeper dynamic evolving — providing a bridging mechanism between regulated natural medicines and primary health care practitioners, and Topricin’s history as a viable tool in addressing and reversing the epidemic of Rx opioid addiction in the U.S. Topricin®, a non-prescription non-chemical pain relief topical biomedicine, works synergistically in assisting and balancing the body’s healing chemistries, providing an optimized healing environment for cellular repair of cells that are causing the pain. Topricin has earned a sterling reputation with practitioners and patients for providing robust health benefits that include: reducing need/dependency for all classifications of oral pain medication, reducing or eliminating the need and side effects of the typically prescribed Rx nerve pain medication for both chemo-induced and diabetic neuropathy, and reducing post-surgically the reduction of pain and edema, time of recovery, and improving outcomes. In 2009, Topricin products were awarded a patent for the topical treatment of pain associated with neuropathy and fibromyalgia. All Topricin products are made in the U.S.A., and available in pharmacies and other fine retailers nationwide.